MedPath

Randomised trial comparing controlled oxygen therapy with high-flow oxygen therapy in the treatment of patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in the pre-hospital setting

Phase 1
Completed
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
Respiratory - Chronic obstructive pulmonary disease
Registration Number
ACTRN12609000236291
Lead Sponsor
Associate Professor Richard Wood-Baker
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
150
Inclusion Criteria

Confirmed Diagnosis COPD, acute respiratory symptoms, Transport and treatment by Tasmanian Ambulance Staff

Exclusion Criteria

Asthma patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality, death in hospital post treatment by ambulance offerers for AECOPD, or death during the care of ambulance officers[Mortality during hospital stay after transport by ambulance and treated for AECOPD, during this episode only]
Secondary Outcome Measures
NameTimeMethod
ventilation - invasive and non invasive required during treatment by Ambulance officers of during stay in hospital after treated pre-hospitally for AECOPD[ventilation required during transport or duing hospital admission after transport by Ambulance officers and treated for AECOPD];arterial blood gas (ABG) results assess within 30 min of arrival after treatment by ambulance for AECOPD[Hospital admission within 30min of arrival];Length of Hospital Stay[after treatment for AECOPD by ambulance officers the length of hospital stay during this admission measured in days]
© Copyright 2025. All Rights Reserved by MedPath